Summary & Overview
CPT 2060F: Clinical Assessment / Status Measure
CPT code 2060F denotes a clinical assessment or status-related performance measure used in outpatient care documentation. While the source description for this code is missing, such codes are nationally relevant because they standardize reporting of patient condition and support quality measurement, care coordination, and claims adjudication across payers. Coverage and application of the code affect billing consistency and quality reporting workflows for clinicians and billing teams.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on the code’s clinical context, expected service setting, and the payers commonly involved in coverage and processing. The publication also summarizes available benchmarks, common billing considerations, and recent policy update themes that influence use of assessment and status measures at the national level.
This executive summary provides a high-level orientation for revenue cycle leaders, compliance officers, and clinicians seeking to understand where CPT code 2060F fits within outpatient documentation and payer interactions. Data not available in the input will be identified explicitly in the detailed sections.
Billing Code Overview
CPT code 2060F has no summary available in the source description. Based on the code label, this entry represents a clinical assessment or status-related performance measure tied to an element of patient condition or care documentation. Service type: Clinical assessment/quality measure. Typical site of service: Ambulatory clinic or outpatient setting.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an ambulatory surgical center or hospital outpatient department with a symptomatic benign subcutaneous mass (for example, a ganglion cyst or small lipoma) or with a painful foreign body localized to the upper or lower extremity. The patient has persistent focal pain, cosmetic concern, or functional limitation after conservative management and elects for minor excision. Pre-procedure evaluation includes focused history, physical exam, informed consent, and confirmation of lesion location with imaging when indicated (ultrasound or radiograph). Procedure workflow: patient is placed in a procedure room or minor operating suite; local anesthesia (with or without light sedation) is administered; sterile technique is used; incision made directly over lesion; careful dissection to identify and excise the mass or remove foreign body; hemostasis achieved; wound irrigated and closed with sutures or adhesive; dressings applied and discharge with wound care instructions. Typical sites of service are ambulatory surgical centers, hospital outpatient departments, or office-based procedure rooms when facility rules permit. Peri-procedural documentation includes indication, lesion size and location, anesthesia type, estimated blood loss, specimens sent for pathology if applicable, and post-procedure instructions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service on the same day as the procedure | Use when a distinct E/M visit is performed and documented on the same date as the procedure |